M. Kay Washington

2.5k citations
34 papers · 1.6k indexed · h-index 20

M. Kay Washington

33 papers receiving 1.5k citations

Peers

M. Kay Washington
Comparison fields: 5 of 101
  • Oncology 556
  • Cancer Research 284
  • Hepatology 132
  • Pathology and Forensic Medicine 232
  • Molecular Biology 738
Replace Kazuo Yashima with:
Kazuo Yashima Japan
Scott K. Kuwada United States
Hideo Shimura Japan
Ruben R. Plentz Germany
Ken-ichi Inada Japan
M Moorghen United Kingdom
Yasunobu Matsuda Japan
Wesley R. Gage United States
Min Sun Shin United States
Masaharu Sumii Japan
M. Kay Washington relative to Kazuo Yashima Japan Kazuo Yashima's profile →
Citations per field
00.5×1.5×1.9×
Kazuo Yashima · 1×
Citations per year

Countries citing papers authored by M. Kay Washington

Since Specialization
Citations

This map shows the geographic impact of M. Kay Washington's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Kay Washington with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Kay Washington more than expected).

Fields of papers citing papers by M. Kay Washington

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Kay Washington. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Kay Washington. The network helps show where M. Kay Washington may publish in the future.

Co-authorship network

The 25 scholars most cited alongside M. Kay Washington, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with M. Kay Washington Line = papers co-authored together M. Kay Washington links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20240
2 20223
3 202227
4 20199
5 20168
6 201518
7 201336
8 201339
9 201238
10 2011151
11 20108
12 200912
13 200997
14 200465
15 200315
16 200375
17 200215
18 200256
19 2000158
20 199631

About M. Kay Washington

M. Kay Washington is a scholar working on Oncology, Pharmacy and Pathology and Forensic Medicine, having authored 34 papers that have together received 1.6k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (7 papers), Genetic factors in colorectal cancer (6 papers), Cancer-related gene regulation (3 papers), Gastric Cancer Management and Outcomes (3 papers), Biomedical and Engineering Education (3 papers), Biomedical Text Mining and Ontologies (3 papers), TGF-β signaling in diseases (3 papers) and NF-κB Signaling Pathways (3 papers). The work is most often cited by research in Oncology (556 citations), Cancer Research (284 citations) and Hepatology (132 citations). M. Kay Washington has collaborated with scholars based in United States, South Africa and United Kingdom. Frequent co-authors include R. Daniel Beauchamp, Natasha G. Deane, Anna L. Means, Robert L. Fine, Gerald R. Hankins, Angus T. De Souza, T.C. Orton, Radhika Aramandla, Rebecca L. Shattuck-Brandt and Raymond N. DuBois. Their work appears in journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Gastroenterology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026